European Pension Funds and Endowments Rekindle Interest in Private Equity Investments in China
PorAinvest
miércoles, 1 de octubre de 2025, 6:13 pm ET2 min de lectura
CG--
The renewed interest in China is driven by several factors. Firstly, the Chinese market is booming due to optimism over technology breakthroughs and economic growth. Secondly, there is a shift away from the US, partly due to President Donald Trump's tariff policies, which have stoked interest in China. Additionally, some investors expect the US to roll back its outbound investment curbs, further encouraging investment in China [1].
Despite the increased interest, China's climb back to its previous prominence in private equity will be steep. Global investors have sharply reduced their allocations to China, dragging down Asia's share of private equity fundraising to multi-year lows. In 2024, Asia made up just 7% of global PE fundraising, compared to 13% in 2021 [1]. Furthermore, China's share of Asia-Pacific deal value fell to just 27% in 2024, down from more than half in 2020 [1].
The private equity industry has reassessed China, with larger firms pausing or pulling back from deals since 2022. Larger PE firms participated in just 6% of the deal value in China last year, down from an average of 24% between 2018 and 2023 [1]. While North American investors remain largely against investing in China, certain European investors, particularly in Scandinavia, are also hesitant due to concerns over supporting Russia's war effort [1].
Recent months have shown signs of increased private equity dealmaking in China. In August, TPG and the Qatar Investment Authority offered to buy out Hong Kong-listed Kangji Medical Holdings Ltd. in a deal valuing the Chinese medical device maker at about $1.4 billion. Meanwhile, KKR & Co. is nearing the acquisition of an 85% stake in Chinese soda maker Dayao Beverage, valued at around $1 billion [1].
Vishal Mahadevia, head of Asia private equity at Warburg Pincus, believes now is a good time to get back into China. "It's the second-largest economy in the world and it would be smart to have a presence there to build a diversified global portfolio," he said in a recent interview [1]. However, capital deployment will remain limited until investors see a series of sizable investments and exits in China, serving as critical signals that the market has truly returned.
In conclusion, European pension funds and endowments are re-evaluating their investment strategies in China. While the market presents opportunities, it also comes with significant risks and uncertainties. Investors should carefully consider these factors before making any investment decisions.
European pension funds and endowments are re-exploring private equity investments in China after years of shunning the country. Firms such as Carlyle Group, Warburg Pincus, and PAG are fielding inquiries from global investors. However, China's climb back to prominence in private equity will be steep, given reduced allocations to the country and a decline in Asia's share of private equity fundraising to multi-year lows.
European pension funds and endowments are once again exploring private equity investments in China after years of shunning the country. Firms such as Carlyle Group, Warburg Pincus, and PAG are fielding inquiries from global investors, according to people familiar with the matter [1]. This shift is a stark contrast to the past few years when political tensions and China's crackdown on private enterprise led to a decline in investment.The renewed interest in China is driven by several factors. Firstly, the Chinese market is booming due to optimism over technology breakthroughs and economic growth. Secondly, there is a shift away from the US, partly due to President Donald Trump's tariff policies, which have stoked interest in China. Additionally, some investors expect the US to roll back its outbound investment curbs, further encouraging investment in China [1].
Despite the increased interest, China's climb back to its previous prominence in private equity will be steep. Global investors have sharply reduced their allocations to China, dragging down Asia's share of private equity fundraising to multi-year lows. In 2024, Asia made up just 7% of global PE fundraising, compared to 13% in 2021 [1]. Furthermore, China's share of Asia-Pacific deal value fell to just 27% in 2024, down from more than half in 2020 [1].
The private equity industry has reassessed China, with larger firms pausing or pulling back from deals since 2022. Larger PE firms participated in just 6% of the deal value in China last year, down from an average of 24% between 2018 and 2023 [1]. While North American investors remain largely against investing in China, certain European investors, particularly in Scandinavia, are also hesitant due to concerns over supporting Russia's war effort [1].
Recent months have shown signs of increased private equity dealmaking in China. In August, TPG and the Qatar Investment Authority offered to buy out Hong Kong-listed Kangji Medical Holdings Ltd. in a deal valuing the Chinese medical device maker at about $1.4 billion. Meanwhile, KKR & Co. is nearing the acquisition of an 85% stake in Chinese soda maker Dayao Beverage, valued at around $1 billion [1].
Vishal Mahadevia, head of Asia private equity at Warburg Pincus, believes now is a good time to get back into China. "It's the second-largest economy in the world and it would be smart to have a presence there to build a diversified global portfolio," he said in a recent interview [1]. However, capital deployment will remain limited until investors see a series of sizable investments and exits in China, serving as critical signals that the market has truly returned.
In conclusion, European pension funds and endowments are re-evaluating their investment strategies in China. While the market presents opportunities, it also comes with significant risks and uncertainties. Investors should carefully consider these factors before making any investment decisions.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios